![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 46, 42645-42657, November 16, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Amyloid Peptide 2-42 in Sporadic and Familial
Alzheimer's Disease and Its Generation in PS1 Knockout Cells*
From the a Department of Psychiatry,
Molecular Neurobiology, and k Department of Biochemistry II,
University of Göttingen, D-37073 Göttingen, Germany,
e Center for Human Genetics, Neuronal Cell Biology Group,
Flanders Interuniversity Institute for Biotechnology and Catholic
University of Leuven, B-3000 Leuven, Belgium, f Institute
for Neuropathology, Ludwig-Maximilians-Universität, D-81377
Munich, Germany, g Research Institute of Molecular Pharmacology,
D-13125 Berlin, Germany, h Institute for Medical Physics and
Biophysics, University of Münster, D-48129 Münster,
Germany, i Department of Psychiatry, University of Hamburg,
D-20246 Hamburg, Germany, and j Department of Psychiatry,
University of Erlangen, D-91054 Erlangen, Germany
Urea-based
-amyloid (A
)
SDS-polyacrylamide gel electrophoresis and immunoblots were used to
analyze the generation of A
peptides in conditioned medium from
primary mouse neurons and a neuroglioma cell line, as well as in human
cerebrospinal fluid. A comparable and highly conserved pattern of A
peptides, namely, 1-40/42 and carboxyl-terminal-truncated 1-37,
1-38, and 1-39, was found. Besides A
1-42, we also observed a
consistent elevation of amino-terminal-truncated A
2-42 in a
detergent-soluble pool in brains of subjects with Alzheimer's disease.
A
2-42 was also specifically elevated in cerebrospinal fluid samples
of Alzheimer's disease patients. To decipher the contribution of
potential different
-secretases (presenilins (PSs)) in generating
the amino-terminal- and carboxyl-terminal-truncated A
peptides, we
overexpressed
-amyloid precursor protein (APP)-trafficking mutants
in PS1+/+ and PS1
/
neurons. As compared with APP-WT (primary
neurons from control or PS1-deficient mice infected with Semliki Forest
virus), PS1
/
neurons and PS1+/+ neurons overexpressing APP-
ct (a
slow-internalizing mutant) show a decrease of all secreted A
peptide
species, as expected, because this mutant is processed mainly by
-secretase. This drop is even more pronounced for the APP-KK
construct (APP mutant carrying an endoplasmic reticulum retention
motif). Surprisingly, A
2-42 is significantly less affected in
PS1
/
neurons and in neurons transfected with the
endocytosis-deficient APP-
ct construct. Our data confirm that PS1 is
closely involved in the production of A
1-40/42 and the
carboxyl-terminal-truncated A
1-37, A
1-38, and A
1-39, but
the amino-terminal-truncated and carboxyl-terminal-elongated A
2-42
seems to be less affected by PS1 deficiency. Moreover, our
results indicate that the latter A
peptide species could be
generated by a
Asp/Ala-secretase activity.
This article has been cited by other articles:
![]() |
W.-P. Chang, D. Downs, X.-P. Huang, H. Da, K.-M. Fung, and J. Tang Amyloid-beta reduction by memapsin 2 (beta-secretase) immunization FASEB J, October 1, 2007; 21(12): 3184 - 3196. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Watzlawik, L. Skora, D. Frense, C. Griesinger, M. Zweckstetter, W. J. Schulz-Schaeffer, and M. L. Kramer Prion Protein Helix1 Promotes Aggregation but Is Not Converted into beta-Sheet. J. Biol. Chem., October 6, 2006; 281(40): 30242 - 30250. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tolia, L. Chavez-Gutierrez, and B. De Strooper Contribution of Presenilin Transmembrane Domains 6 and 7 to a Water-containing Cavity in the {gamma}-Secretase Complex J. Biol. Chem., September 15, 2006; 281(37): 27633 - 27642. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bibl, B. Mollenhauer, H. Esselmann, P. Lewczuk, H.-W. Klafki, K. Sparbier, A. Smirnov, L. Cepek, C. Trenkwalder, E. Ruther, et al. CSF amyloid-{beta}-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia Brain, May 1, 2006; 129(5): 1177 - 1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lewczuk, G. Beck, H. Esselmann, R. Bruckmoser, R. Zimmermann, M. Fiszer, M. Bibl, J. M. Maler, J. Kornhuber, and J. Wiltfang Effect of Sample Collection Tubes on Cerebrospinal Fluid Concentrations of Tau Proteins and Amyloid {beta} Peptides Clin. Chem., February 1, 2006; 52(2): 332 - 334. [Full Text] [PDF] |
||||
![]() |
H. Vanderstichele, G. De Meyer, N. Andreasen, V. Kostanjevecki, A. Wallin, A. Olsson, K. Blennow, and E. Vanmechelen Amino-Truncated {beta}-Amyloid42 Peptides in Cerebrospinal Fluid and Prediction of Progression of Mild Cognitive Impairment Clin. Chem., September 1, 2005; 51(9): 1650 - 1660. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pitsi and J.-N. Octave Presenilin 1 Stabilizes the C-terminal Fragment of the Amyloid Precursor Protein Independently of {gamma}-Secretase Activity J. Biol. Chem., June 11, 2004; 279(24): 25333 - 25338. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Bazan and W. J. Lukiw Cyclooxygenase-2 and Presenilin-1 Gene Expression Induced by Interleukin-1beta and Amyloid beta 42 Peptide Is Potentiated by Hypoxia in Primary Human Neural Cells J. Biol. Chem., August 9, 2002; 277(33): 30359 - 30367. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |